By employing multiple functional analyses, we demonstrate that inhibition of single PAM pathway nodes is less effective than pan-PI3K/mTOR inhibition at controlling PAM pathway activity and downstream cellular functions, such as protein synthesis, metabolism, cell cycle progression, survival, and proliferation in BC cells with mutant or wild type PAM pathway status. Here, PIK3CG is linked to breast cancer.